Why ON Semiconductor (ON) Stock Rallied: Dilution Risk Eliminated in Revised Synaptics Acquisition

TLDR

• ON Semiconductor restructured its Synaptics acquisition into a $5.7 billion all-cash transaction, reduced from the initial $7 billion stock-based proposal.
• Under the updated terms, Synaptics shareholders will receive $123 cash per share rather than the previously offered 1.350 ON shares.
• Premarket trading saw ON stock surge approximately 6%, while Synaptics shares climbed roughly 14%.
• The revised agreement eliminates shareholder dilution concerns and promises immediate accretion to earnings.
• Regulatory approvals and Synaptics shareholder consent remain required, with completion anticipated by mid-2027.

Shares of ON Semiconductor rallied approximately 6% during Friday’s premarket session following the company’s announcement of a restructured takeover agreement for Synaptics. The previous trading day had seen ON close at $80.08.

ON Semiconductor Corporation, ON

Synaptics experienced an even stronger rally, climbing approximately 14% after the announcement. Both semiconductor manufacturers produce chip solutions for automotive, industrial, and IoT applications.

When initially announced last June, the transaction was structured entirely as a stock exchange. Each Synaptics shareholder would have received 1.350 shares of ON stock, creating a deal valued around $7 billion.

The companies have now completely restructured the arrangement as an all-cash purchase. Synaptics shareholders will instead receive $123 cash per share, reducing the total transaction value to approximately $5.7 billion.

The reduced valuation emerged following an unsolicited competing proposal for Synaptics from an unnamed third party. Rather than triggering an escalating bidding contest, the development prompted both parties to negotiate terms more favorable to their respective shareholders.

Why the Cash Deal Makes Sense for ON

The cash structure shields ON shareholders from the dilution inherent in the original stock-issuance plan. This change eliminates a significant concern that had pressured the stock since the June announcement.

According to ON’s management, the restructured transaction will immediately enhance non-GAAP earnings per share. This marks a meaningful improvement over the original arrangement, which lacked immediate accretion.

ON had previously identified $200 million in annual cost synergies from combining operations. Management now sees opportunities for additional value creation, including revenue synergies and in-sourcing certain Synaptics production activities.

The transaction will be funded through existing cash reserves and debt facilities arranged with Morgan Stanley. Notably, the agreement contains no financing contingency, eliminating another potential obstacle to completion.

What Synaptics Investors Get

Synaptics CEO Rahul Patel characterized the cash structure as delivering certainty to shareholders. “We are providing value certainty at a premium as compared to current value,” he said.

The tradeoff is straightforward. Synaptics shareholders forfeit potential participation in the combined entity’s future performance but receive guaranteed proceeds instead.

Following the announcement, Robert W. Baird analyst Tristan Gerra maintained a Hold rating on ON with a $108 price target. The broader analyst community assigns ON a Moderate Buy consensus, while Synaptics holds a Hold rating.

Market conditions also proved favorable. Micron’s robust earnings report released the previous evening had already buoyed semiconductor stocks broadly, providing additional momentum for ON’s announcement.

Simultaneously, Treasury yields retreated from recent peaks that morning, relieving pressure on growth-oriented equities.

The transaction remains subject to approval from Synaptics shareholders and multiple regulatory bodies. While the FTC has already granted clearance, reviews in additional jurisdictions continue.

The parties expect to finalize the transaction by mid-2027. Between now and closing, both stocks will likely respond to developments in the approval process.